Orexin-A is an orexigenic peptide expressed mainly in the hypothalamus. Orexin-A increases and anti-orexin-A antibodies decrease food intake. However, the exact mechanism by which orexin-A exerts its orexigenic action is not fully elucidated. The histaminergic system is known to play a role in feeding behavior and we hypothesized that it could be involved in the orexigenic effect of orexin-A. To study this, we used histamine knockout animals and pharmacological blockade of the histaminergic system and studied the effect of orexin-A on feeding behavior and gene expression of neuropeptide Y (NPY). Orexin-A was administered intracerebroventricularly and food intake measured in wild-type, histamine H1-receptor knockout or histidine decarboxylase knockout mice. Additionally, we administered orexin-A to wild-type mice with pharmacologically blocked H1-receptors or pharmacologically stimulated autoinhibitory H3-receptors. By quantitative real-time PCR we measured the effect of orexin-A on NPY mRNA expression in wild-type and knockout mice. Orexin-A dose-dependently stimulated food intake when administered to wild-type mice in doses up to 0.03 µg. Orexin-A in a dose of 0.01 µg increased food intake 10-fold in wild-type mice, whereas no increase in food intake was seen in either knockout mice or pharmacologically manipulated mice. Orexin-A increased NPY mRNA 4-fold in wild-type mice, whereas no change was observed in knockout mice. We conclude that the orexigenic effect of orexin-A is dependent on an intact histaminergic neuronal system and seems to involve an H1-receptor mechanism.

Keywords:
Orexins, Histamine, Feeding behavior, Transgenic mice, Neuropeptide Y
1.
Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68–100.
2.
De LL, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG: The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998;95:322–327.
3.
Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM: Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998;438:71–75.
4.
Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S: Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001;12:993–997.
5.
Lopez M, Seoane L, Garcia MC, Lago F, Casanueva FF, Senaris R, Dieguez C: Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 2000;269:41–45.
6.
Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573–585.
7.
Yamada H, Okumura T, Motomura W, Kobayashi Y, Kohgo Y: Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem Biophys Res Commun 2000;267:527–531.
8.
Dube MG, Kalra SP, Kalra PS: Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 1999;842:473–477.
9.
Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR: The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 1999;160:R7–R12.
10.
Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JR: Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 1999;20:1099–1105.
11.
Ida T, Nakahara K, Katayama T, Murakami N, Nakazato M: Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 1999;821:526–529.
12.
Jain MR, Horvath TL, Kalra PS, Kalra SP: Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul Pept 2000;87:19–24.
13.
Lopez M, Seoane LM, Garcia MC, Dieguez C, Senaris R: Neuropeptide Y, but not agouti-related peptide or melanin-concentrating hormone, is a target peptide for orexin-A feeding actions in the rat hypothalamus. Neuroendocrinology 2002;75:34–44.
14.
Lubkin M, Stricker-Krongrad A: Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 1998;253:241–245.
15.
Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Blundell JE: Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept 2000;96:71–84.
16.
Sweet DC, Levine AS, Billington CJ, Kotz CM: Feeding response to central orexins. Brain Res 1999;821:535–538.
17.
Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, Miwa Y, Goto K, Sakurai T: Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 2000;859:404–409.
18.
Muroya S, Funahashi H, Yamanaka A, Kohno D, Uramura K, Nambu T, Shibahara M, Kuramochi M, Takigawa M, Yanagisawa M, Sakurai T, Shioda S, Yada T: Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur J Neurosci 2004;19:1524–1534.
19.
Dube MG, Horvath TL, Kalra PS, Kalra SP: Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats. Peptides 2000;21:1557–1560.
20.
Ida T, Nakahara K, Kuroiwa T, Fukui K, Nakazato M, Murakami T, Murakami N: Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci Lett 2000;293:119–122.
21.
Morimoto T, Yamamoto Y, Yamatodani A: Brain histamine and feeding behavior. Behav Brain Res 2001;124:145–150.
22.
Ookuma K, Yoshimatsu H, Sakata T, Fujimoto K, Fukagawa F: Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res 1989;490:268–275.
23.
Fukagawa K, Sakata T, Shiraishi T, Yoshimatsu H, Fujimoto K, Ookuma K, Wada H: Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus. Am J Physiol 1989;256:R605–R611.
24.
Machidori H, Sakata T, Yoshimatsu H, Ookuma K, Fujimoto K, Kurokawa M, Yamatodani A, Wada H: Zucker obese rats: defect in brain histamine control of feeding. Brain Res 1992;590:180–186.
25.
Mercer LP, Kelley DS, Humphries LL, Dunn JD: Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats. J Nutr 1994;124:1029–1036.
26.
Sakata T, Ookuma K, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T, Wada H: Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res 1988;441:403–407.
27.
Sakata T, Fukagawa K, Ookuma K, Fujimoto K, Yoshimatsu H, Yamatodani A, Wada H: Hypothalamic neuronal histamine modulates ad libitum feeding by rats. Brain Res 1990;537:303–306.
28.
Orthen-Gambill N, Salomon M: FMH-induced decrease in central histamine levels produces increased feeding and body weight in rats. Physiol Behav 1992;51:891–893.
29.
Tuomisto L, Yamatodani A, Jolkkonen J, Sainio EL, Airaksinen MM: Inhibition of brain histamine synthesis increases food intake and attenuates vasopressin response to salt loading in rats. Methods Find Exp Clin Pharmacol 1994;16:355–359.
30.
Vaziri P, Dang K, Anderson GH: Evidence for histamine involvement in the effect of histidine loads on food and water intake in rats. J Nutr 1997;127:1519–1526.
31.
Doi T, Sakata T, Yoshimatsu H, Machidori H, Kurokawa M, Jayasekara LA, Niki N: Hypothalamic neuronal histamine regulates feeding circadian rhythm in rats. Brain Res 1994;641:311–318.
32.
Tamiya R, Hanada M, Narita N, Kawai Y, Tohyama M, Takagi H: Neuropeptide Y afferents have synaptic interactions with histaminergic (histidine decarboxylase-immunoreactive) neurons in the rat brain. Neurosci Lett 1989;99:241–245.
33.
Itoh E, Fujimiya M, Inui A: Thioperamide, a histamine H3 receptor antagonist, suppresses NPY- but not dynorphin A-induced feeding in rats. Regul Pept 1998;75–76:373–376.
34.
Eriksson KS, Sergeeva O, Brown RE, Haas HL: Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001;21:9273–9279.
35.
Ishizuka T, Yamamoto Y, Yamatodani A: The effect of orexin-A and -B on the histamine release in the anterior hypothalamus in rats. Neurosci Lett 2002;323:93–96.
36.
Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JL, Wang QP, Tominaga M, Goto K, Shioda S, Sakurai T: Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 2002;290:1237–1245.
37.
Backberg M, Hervieu G, Wilson S, Meister B: Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur J Neurosci 2002;15:315–328.
38.
Inoue I, Yanai K, Kitamura D, Taniuchi I, Kobayashi T, Niimura K, Watanabe T, Watanabe T: Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 1996;93:13316–13320.
39.
Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, Hirasawa N, Sakurai E, Buzas E, Kovacs P, Csaba G, Kittel A, Okada M, Hara M, Mar L, Numayama-Tsuruta K, Ishigaki-Suzuki S, Ohuchi K, Ichikawa A, Falus A, Watanabe T, Nagy A: Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001;502:53–56.
40.
Toftegaard CL, Knigge U, Kjaer A, Watanabe T, Friis-Hansen L, Warberg J: Effect of interleukin 1beta on the HPA axis in H1-receptor knockout mice. Neuroimmunomodulation 2002;10:344–350.
41.
Harbuz MS, Lightman SL: Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol 1989;122:705–711.
42.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–408.
43.
Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N: Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 2000;270:318–323.
44.
Glowa JR, Barrett JE, Russell J, Gold PW: Effects of corticotropin releasing hormone on appetitive behaviors. Peptides 1992;13:609–621.
45.
Fulop AK, Foldes A, Buzas E, Hegyi K, Miklos IH, Romics L, Kleiber M, Nagy A, Falus A, Kovacs KJ: Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene. Endocrinology 2003;144:4306–4314.
46.
Masaki T, Chiba S, Yasuda T, Noguchi H, Kakuma T, Watanabe T, Sakata T, Yoshimatsu H: Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 2004;53:2250–2260.
47.
Merali Z, Banks K: Does the histaminergic system mediate bombesin/GRP-induced suppression of food intake? Am J Physiol 1994;267:R1589–R1595.
48.
Lecklin A, Etu-Seppala P, Stark H, Tuomisto L: Effects of intracerebroventricularly infused histamine and selective H1, H2 and H3 agonists on food and water intake and urine flow in Wistar rats. Brain Res 1998;793:279–288.
© 2005 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.